A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer

Authors: E-J Choi, B-J Jung, S-H Lee, H-S Yoo, E-A Shin, Hyun‐Jeong Ko, Suhwan Chang, S-Y Kim, S-M Jeon - Oncogene 2017 cited by 121